Brief: Can-Fite Expands Its Namodenoson Distribution Deal With CKD In South Korea With Nash Indication

Chong Kun Dang Pharmaceutical

25/02/2019 12:16

Feb 25 (Reuters) - Can Fite Biopharma Ltd  CANF.TA :
    * CAN-FITE EXPANDS ITS NAMODENOSON DISTRIBUTION DEAL WITH
CKD IN
SOUTH KOREA WITH NASH INDICATION
    * CKD WILL RECEIVE EXCLUSIVE RIGHTS TO DISTRIBUTE
NAMODENOSON FOR
TREATMENT OF NASH IN ADDITION TO LIVER CANCER IN SOUTH KOREA
    * CKD TO PAY CO $1 MILLION UPFRONT UPON SIGNING, WITH UP TO
ADDITIONAL $5 MILLION UPON ACHIEVING CERTAIN MILESTONES

Source text for Eikon:  ID:nBw5hBfqHa 
Further company coverage:  CANF.TA 

 ((Reuters.Briefs@thomsonreuters.com;))